CDK4 and neoplasm: Whereas it was absent in normal pleura, CDK4 phosphorylation was detected with variable abundance in 39 of 47 tumours, suggesting that about 80% of patients could respond to CDK4/6 inhibition (Fig. 6A; Fig. S7).